Johnson & Johnson pauses Covid-19 vaccine trials due to unexplained illness in participant

Johnson & Johnson pauses Covid-19 vaccine trials due to unexplained illness in participant
Johnson & Johnson pauses Covid-19 vaccine trials due to unexplained illness in participant

Hello and welcome to the details of Johnson & Johnson pauses Covid-19 vaccine trials due to unexplained illness in participant and now with the details

Nevin Al Sukari - Sana'a - Stat News reported the pause earlier in the day citing a document sent to outside researchers running the 60,000-patient clinical trial. — Reuters pic

NEW YORK, Oct 13 — Johnson & Johnson said yesterday it has temporarily paused its Covid-19 vaccine candidate clinical trials due to an unexplained illness in a study participant.

The participant's illness is being reviewed and evaluated by an independent data and safety monitoring board as well as the company's clinical and safety physicians, it said in a statement.

Stat News reported the pause earlier in the day citing a document sent to outside researchers running the 60,000-patient clinical trial, which stated that a "pausing rule" had been met, the online system used to enroll patients in the study had been closed and the data and safety monitoring board would be convened. — Reuters

These were the details of the news Johnson & Johnson pauses Covid-19 vaccine trials due to unexplained illness in participant for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

PREV N. Korea fires multiple short-range ballistic missiles, Seoul says
NEXT Top French university loses funding over pro-Palestinian protests